Patent · US Active

Intraocular drug delivery systems

US8969415B2 · kind B2 · utility

13Cited by

141References

2Claims

0Family size

Assignee

Allergan, Inc. · US

Inventors

Michael R. Robinson · Irvine, US
Wendy M. Blanda · Tustin, US
Patrick M. Hughes · Aliso Viejo, US
Guadalupe Ruiz · Corona, US
Werhner C. Orilla · Anaheim, US
Scott M. Whitcup · Laguna Hills, US
Devin F. Welty · Ann Arbor, US
Joan-En Lin · Tustin, US
Lon T. Spada · Walnut, US

Key dates

Filing date	Dec 1, 2006
Grant date	Mar 3, 2015
Priority date	—
Expiry date	Mar 9, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 10 days and one year or longer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.